Recent News

• 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.11.2025 - Leerink's Global Biopharma Conference 2025
• 03.11.2025 - Leerink's Global Biopharma Conference 2025
• 03.10.2025 - MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
• 03.10.2025 - MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
• 02.26.2025 - MannKind Corporation Fourth Quarter 2024 Earnings Call
• 02.26.2025 - MannKind Corporation Fourth Quarter 2024 Earnings Call
• 02.26.2025 - MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
• 02.26.2025 - MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
• 02.19.2025 - MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025

Recent Filings

• 02.26.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.26.2025 - EX-99.1 EX-99.1
• 02.26.2025 - 8-K Current report
• 02.26.2025 - S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
• 02.13.2025 - 4 Statement of changes in beneficial ownership of securities